Escitalopram Oxalate
Product Images NDC 10544-224

This is a description of medication called Escitalopram Tablets, USP with dosage of 10mg. The box contains 30 tablets and it is available only with a prescription. It comes with a package insert with the dosage information. The drug should be stored at controlled room temperature ranging from 20°-25°C (68"-77°F) with permissible excursions up to 15°-30°C (3% 86°F). The information about the manufacturer and the lot number with expiry date are provided on the box. There are separate details for 4 boxes with different lot numbers and no information related to any side effects.*

This is a description of a medication called Escitalopram Tablets, USP 20mg that comes in a package of 30 tablets. It is a prescription drug that should be stored within controlled room temperature of 20°-25°C (68°77°F) and it is only available with a prescription. The package insert should be read for the dosage. The medication is to be kept in a light-resistant container, out of children's reach, and excursions are permitted between 15%-30°C (59°-85°F). It is packaged by Blenheim Pharmacal, Inc., and the lot number is BPODODODOD with an expiration date of 00/00/0000. There are several other variations of the medication that have the same NDC number, with different manufacturing codes, lot numbers, and expiration dates.*

This is information about the drug Escitalopram in the form of tablets. It is available in 5mg strength and packaged in a container with 30 tablets. This medicine is only available by prescription and must be stored at a controlled room temperature of 20°-25°C (5B-77°F). The lot number and expiration date are also mentioned on the label. It is important to keep this medicine out of the reach of children.*

This is a table showing treatment-emergent adverse reactions observed in patients with Major Depressive Disorder. The reactions listed occurred with a frequency of greater than 2% and were greater than placebo. The table compares the reactions associated with Escitalopram Oxalate versus Placebo administrations. The reactions have been categorized under Autonomic Nervous System Disorders, Central & Peripheral Nervous System Disorders, Gastrointestinal Disorders, General, Psychiatric Disorders, Respiratory System Disorders, and Urogenital. Ejaculation Disorder, Impotence, and Anorgasmia were observed in males and Insomnia and Somnolence in females.*

This is a table showing the treatment-emergent adverse reactions with a frequency of greater than 2% and greater than placebo for Generalized Anxiety Disorder. The adverse reactions are grouped by body system including Autonomic Nervous System Disorders, Central & Peripheral Nervous System Disorders, Gastrointestinal Disorders, General, Musculoskeletal System Disorder, Psychiatric Disorders, Respiratory System Disorders, and Trogenital. The adverse reactions with their corresponding percentage are listed for both Escitalopram and Placebo groups. The denominators used for the calculations are also provided.*